AzTrials
AzTrials

Domestic ViolenceDVHPDINCT02021838

Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative

An observational study of Domestic Violence, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Domestic Violence
What is being tested?
Lethality Assessment Program and Domestic Violence High Risk Team
How many people
666 participants
Where
1 siteUnited States
Study dates
1 Jan 2014to 31 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study will include all domestic violence offenders and victims within the six communities.

The demonstration sites are:

California North Carolina Ohio Illinois Michigan Tennessee

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale University

    New Haven, Connecticut, 06511

Other trials in United States

About this study

Official title: Evaluation of the Domestic Violence Homicide Prevention Initiative

In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.

Read the detailed description

Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.

Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.

Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".

Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.

System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.

Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.

Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.

Being tested
Lethality Assessment Program, Domestic Violence High Risk Team
Keywords
domestic violence homicide prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lethality Assessment ProgramOther

    Also called LAP

    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.

  • Domestic Violence High Risk TeamOther

    Also called HRT

    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress.

Study groups in NCT02021838
Study groupRoleWhat they receive
CaliforniaLethality Assessment Program
Receives: Other: Lethality Assessment Program
North CarolinaLethality Assessment Program
Receives: Other: Lethality Assessment Program
OhioDomestic Violence High Risk Team
Receives: Other: Domestic Violence High Risk Team
IllinoisLethality Assessment Program
Receives: Other: Lethality Assessment Program
MichiganLethality Assessment Program
Receives: Other: Lethality Assessment Program
TennesseeLethality Assessment Program
Receives: Other: Lethality Assessment Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Decreased frequency of re-assault

    Decrease in harassment, assault, injury, homicide/mortality

    Measured: up to 3 years

Secondary outcomes (5)
  1. Increased collaboration between network partners

    Increased information sharing, case planning, coordinated response

    Measured: up to 3 years

  2. Increased awareness of and utilization of resources for victims

    Increased awareness of and utilization of community resources

    Measured: Up to 3 years

  3. Increased safety planning

    Increased safety planning at the time of police intervention

    Measured: Up to 3 years

  4. Increased victim reported safety

    Victim reported changes in perceptions of safety

    Measured: Up to 3 years

  5. Increased sanctions for offender

    Sanctions such as pre-trial containment, cases to trial, adjudications, containment post-adjudication

    Measured: Up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2013 (estimated)
  2. Study start1 Jan 2014
  3. Primary completion31 Dec 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
666 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02021838
Sponsor's protocol ID
1311013010
Acronym
DVHPDI
Status last verified
Mar 2021
First submitted
12 Dec 2013
Last updated
24 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be archived with the National Institute of Justice

Questions about this trial

What is this clinical trial studying?

An observational study of Domestic Violence, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Decreased frequency of re-assault (time frame: up to 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in